8-K - ArriVent BioPharma, Inc. Common Stock | StockGist

Current Report Details

Event Type

Financial Results

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

2.02

and in the press release furnished as Exhibit 99.1 hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amen

Financial Results

9.01

Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press Release dated November 10, 2025. 104 Cover Page Interactive Data File (emb

Exhibits Only

Source Document

Exhibits (2)

8-K

99.1

EX-99.1